Treatment of cancer with carcinostatic and immunostimulating age

Details Treatment of cancer with carcinostatic and immunostimulating age Treatment of cancer with carcinostatic and immunostimulating age

1980-02-29

1983-02-08

Fagelson, Anna P.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant virus encoding one or more heterologous proteins...

424 38, 424365, A61K 31685, A61K 4505

Patent

active

043729495

ABSTRACT:
A carcinostatic and immunostimulating agent containing a lysophospholipid and a phospholipid. Said carcinostatic and immunostimulating agent is useful for the treatment of cancerous diseases of the mammals including human being. This disclosure concerns such a carcinostatic and immunostimulating agent and a process for preparing the same as well as a method for treating the cancerous diseases by using said agent.

REFERENCES:
patent: 3752886 (1973-08-01), Munder
patent: 4119714 (1978-10-01), Kny
Kitagawa, J. Biochem., vol. 79, 1976, pp. 1123-1133.
Sunamoto, Biochim. et Biophys. Acta, vol. 510, 1978, pp. 52-62.
Kinsky, J. Biochem. (Tokyo), vol. 79, 1976, pp. 24P-25P.
Munder, Chem. Abs., vol. 79, 1973, Ab No. 51669p.
Fauve, Chem. Abs., vol. 85, 1976, Ab No. 10434p.
Layton, Arch. Int. de Physiol. et Biochemie, vol. 87, Dec. 1979, pp. 1014-1016
Van Rooijen, Chem. Abs., vol. 88, 1978, Ab 88:20445.
Munder, Clin. Bull., vol. 6, No. 2, 1976, p. 80.

Affiliated with

Also associated with

Rating

Treatment of cancer with carcinostatic and immunostimulating age does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cancer with carcinostatic and immunostimulating age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer with carcinostatic and immunostimulating age will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-49595